ID	Description	GeneRatio	BgRatio	pvalue	qvalue	genes	geneID	Count	clusters	generatio	bgratio
R-HSA-168256	Immune System	54/1840	1707/23216	4.58204696795e-15	2.68049747625e-12	CD74; DTX3L; NCF1; CD40LG; CD4; CD28; PTAFR; ADAM8; NLRC4; NLRC5; NLRC3; DDX58; STAT4; STAT2; STAT1; SLC11A1; CIITA; CD86; IFI16; TNFSF8; S100A9; S100A8; ICAM1; TNFRSF4; RELB; NFKB2; ITGB2; PRKCB; PSMB8; TRIM21; TRIM22; MNDA; LGALS9; LILRB4; FASLG; PYCARD; RHOG; IRF3; RPS6KA1; IRF1; IRF7; NLRP3; IRF9; EIF2AK2; IL16; TLR2; TLR3; NFAM1; TLR6; BTK; OSM; CD3D; HAVCR2; SP100	10346/3689/150372/10379/3965/920/10333/3661/6279/6737/653361/6773/84868/4261/959/23586/3665/391/7097/3659/6772/5610/915/58484/6280/940/6556/6195/6775/11006/6672/84166/197358/972/5579/151636/942/5971/7098/5008/3603/944/7293/3428/114548/3383/101/5724/29108/4332/5696/356/695/4791	54	3	0.0293478260869565	0.073526878015162
R-HSA-1280215	Cytokine Signaling in Immune system	28/458	455/23216	1.84518797806e-14	5.39717483584e-12	CD40LG; CD4; PTAFR; DDX58; STAT4; STAT2; STAT1; CIITA; TNFSF8; OSM; ICAM1; TNFRSF4; RELB; NFKB2; TRIM21; TRIM22; LGALS9; FASLG; IRF3; RPS6KA1; IRF1; IRF7; IRF9; EIF2AK2; IL16; PSMB8; HAVCR2; SP100	959/6672/3665/10346/3603/23586/10379/3965/920/6772/944/7293/3661/6737/3383/6773/5724/5610/84868/4261/6195/3659/5971/5008/6775/5696/356/4791	28	3	0.0611353711790393	0.0195985527222605
R-HSA-913531	Interferon Signaling	15/158	155/23216	6.77571670292e-11	9.90948567802e-09	IRF3; DDX58; IRF7; STAT2; STAT1; CIITA; IRF9; EIF2AK2; TRIM21; TRIM22; PTAFR; ICAM1; PSMB8; IRF1; SP100	6773/5724/4261/6772/6672/3665/6737/10346/3661/23586/3383/5696/5610/10379/3659	15	3	0.0949367088607595	0.00667643004824259
path:hsa05169	Epstein-Barr virus infection - Homo sapiens (human)	16/201	198/23216	2.29942516217e-10	2.26927796203e-08	IRF3; DDX58; EIF2AK2; IRF7; STAT2; STAT1; E2F1; IRF9; CCNA2; TLR2; ICAM1; RELB; CXCL10; NFKB2; CD3D; BTK	3383/23586/3627/3661/3665/6772/6773/10379/4791/1869/5971/890/695/915/7097/5610	16	3	0.0796019900497512	0.00852860096485183
path:hsa05164	Influenza A - Homo sapiens (human)	15/171	169/23216	2.32746457644e-10	2.26927796203e-08	IRF3; DDX58; EIF2AK2; IRF7; STAT1; NLRP3; CIITA; IRF9; PRKCB; TLR3; FASLG; ICAM1; PYCARD; CXCL10; STAT2	23586/3627/3661/3665/3383/114548/6772/6773/10379/4261/356/29108/7098/5579/5610	15	3	0.087719298245614	0.00727946243969676
path:hsa05161	Hepatitis B - Homo sapiens (human)	14/144	144/23216	2.85291703321e-10	2.38422352061e-08	IRF3; DDX58; STAT4; IRF7; STAT2; STAT1; E2F1; BIRC5; PRKCB; TGFB2; TLR2; TLR3; FASLG; CCNA2	23586/3661/3665/6772/6773/6775/332/1869/356/890/7042/7097/7098/5579	14	3	0.0972222222222222	0.0062026188835286
R-HSA-877300	Interferon gamma signaling	11/94	91/23216	2.47098485146e-09	1.60614015345e-07	IRF3; IRF1; IRF7; STAT1; CIITA; IRF9; TRIM21; TRIM22; PTAFR; ICAM1; SP100	5724/4261/6772/6672/6737/3665/10346/3661/3383/10379/3659	11	3	0.117021276595745	0.0039197105444521
WP3858	Toll-like Receptor Signaling	7/31	31/23216	2.47047600621e-08	1.31384405785e-06	IRF3; IRF7; TLR2; TLR3; TLR6; RELB; NFKB2	10333/7097/7098/3665/3661/4791/5971	7	3	0.225806451612903	0.00133528600964852
path:hsa05162	Measles - Homo sapiens (human)	11/132	131/23216	1.1637352538e-07	5.21322880023e-06	IRF3; DDX58; CD28; IRF7; STAT2; STAT1; IRF9; EIF2AK2; TLR2; FASLG; CD3D	23586/3661/3665/356/6772/6773/10379/915/940/7097/5610	11	3	0.0833333333333333	0.00564266023432116
path:hsa04625	C-type lectin receptor signaling pathway - Homo sapiens (human)	10/104	104/23216	1.24761031117e-07	5.21322880023e-06	IRF1; STAT2; STAT1; IRF9; NLRP3; PYCARD; RELB; NFKB2; PLK3; BCL3	3659/602/6772/6773/10379/4791/1263/5971/114548/29108	10	3	0.0961538461538462	0.00447966919365955
WP1449	Regulation of toll-like receptor signaling pathway	11/143	143/23216	2.84902409065e-07	1.04167443314e-05	IRF3; IRF7; STAT1; PLK1; CD86; TLR2; TLR3; TLR6; CXCL10; NFKB2; BTK	3665/10333/3661/695/6772/7097/7098/5347/3627/4791/942	11	3	0.0769230769230769	0.00615954514128187
path:hsa05168	Herpes simplex infection - Homo sapiens (human)	12/185	183/23216	4.56693905241e-07	1.57156432098e-05	IRF3; CD74; DDX58; IRF7; STAT2; STAT1; IRF9; EIF2AK2; TLR2; TLR3; FASLG; SP100	23586/3661/3665/356/6672/6772/6773/10379/7097/7098/972/5610	12	3	0.0648648648648649	0.00788249483115093
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	8/68	68/23216	5.0072582057e-07	1.62735891685e-05	PRKCH; CD40LG; STAT2; STAT1; PRKCB; TLR2; RELB; NFKB2	959/7097/5583/4791/5971/5579/6772/6773	8	3	0.117647058823529	0.0029290144727774
R-HSA-168898	Toll-Like Receptors Cascades	11/154	154/23216	6.0129158354e-07	1.64198041493e-05	IRF3; RPS6KA1; ITGB2; IRF7; TLR2; TLR3; S100A9; S100A8; TLR6; NFKB2; BTK	6279/3665/6195/6280/7098/695/3661/7097/3689/10333/4791	11	3	0.0714285714285714	0.00663335630599586
path:hsa05160	Hepatitis C - Homo sapiens (human)	11/155	155/23216	6.41535767327e-07	1.64198041493e-05	IRF3; DDX58; IRF7; STAT2; STAT1; E2F1; IRF9; EIF2AK2; TLR3; FASLG; CXCL10	3627/3661/3665/6772/6773/10379/23586/1869/356/7098/5610	11	3	0.0709677419354839	0.00667643004824259
path:hsa04380	Osteoclast differentiation - Homo sapiens (human)	10/128	125/23216	7.04552987706e-07	1.71734790753e-05	NCF1; SPI1; STAT2; STAT1; IRF9; TGFB2; LILRB4; RELB; NFKB2; BTK	6688/653361/4791/6772/6773/10379/695/11006/7042/5971	10	3	0.078125	0.0053842177808408
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	4/8	8/23216	7.71634405014e-07	1.80562450773e-05	TLR2; NFKB2; SPI1; APOE	7097/6688/348/4791	4	3	0.5	0.000344589937973811
WP4217	Ebola Virus Pathway on Host	10/130	128/23216	8.77588451572e-07	1.97457401604e-05	IRF3; ACTN1; IRF7; STAT1; EIF2AK2; DDX58; RELB; NFKB2; HAVCR2; CAV1	5610/84868/3665/3661/6772/5971/857/87/23586/4791	10	3	0.0769230769230769	0.00551343900758098
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	7/51	51/23216	9.14435111158e-07	1.98127607418e-05	IRF3; IRF7; TRIM21; TLR3; IFI16; NFKB2; NLRC3	3428/7098/197358/3661/3665/6737/4791	7	3	0.137254901960784	0.00219676085458305
WP75	Toll-like Receptor Signaling Pathway	9/102	102/23216	1.13670227181e-06	2.3748958179e-05	IRF3; IRF7; STAT1; CD86; TLR2; TLR3; TLR6; CXCL10; NFKB2	3665/10333/3661/6772/7097/7098/3627/4791/942	9	3	0.0882352941176471	0.00439352170916609
WP4298	Viral Acute Myocarditis	8/76	76/23216	1.1910191949e-06	2.4025732035e-05	ITGB2; CD40LG; STAT1; CD4; TLR3; PYCARD; NFKB2; CAV1	4791/959/857/7098/3689/6772/29108/920	8	3	0.105263157894737	0.00327360441075121
WP4066	Interleukin-4 and Interleukin-13 signaling	8/97	94/23216	6.00827900306e-06	0.000106510400509	BATF; ITGB2; STAT1; BIRC5; HMOX1; OSM; ICAM1; FASLG	10538/5008/6772/332/3162/3689/3383/356	8	3	0.0824742268041237	0.00404893177119228
toll_endogenous_pathway	Endogenous TLR signaling	5/26	26/23216	6.36341409902e-06	0.000109488154351	TLR2; TLR3; S100A9; S100A8; TLR6	6280/7098/6279/7097/10333	5	3	0.192307692307692	0.00111991729841489
path:hsa04621	NOD-like receptor signaling pathway - Homo sapiens (human)	10/168	166/23216	9.19299487544e-06	0.000149386166726	IRF3; IRF7; STAT2; STAT1; IRF9; CARD16; IFI16; NLRP3; NLRC4; PYCARD	3661/6772/58484/6773/10379/3428/114769/114548/29108/3665	10	3	0.0595238095238095	0.00715024121295658
path:hsa04620	Toll-like receptor signaling pathway - Homo sapiens (human)	8/104	102/23216	1.10382962225e-05	0.000172811805575	IRF3; IRF7; STAT1; CD86; TLR2; TLR3; TLR6; CXCL10	3627/3661/3665/10333/6772/942/7097/7098	8	3	0.0769230769230769	0.00439352170916609
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	6/50	50/23216	1.26475988657e-05	0.000189713982986	CD40LG; TNFSF8; FASLG; TNFRSF4; RELB; NFKB2	5971/959/7293/356/944/4791	6	3	0.12	0.00215368711233632
R-HSA-5686938	Regulation of TLR by endogenous ligand	4/16	16/23216	1.88002606265e-05	0.000255770987594	TLR2; S100A9; TLR6; S100A8	10333/6279/7097/6280	4	3	0.25	0.000689179875947622
R-HSA-1834941	STING mediated induction of host immune responses	4/16	16/23216	1.88002606265e-05	0.000255770987594	IRF3; IFI16; TRIM21; NLRC3	197358/3661/3428/6737	4	3	0.25	0.000689179875947622
path:hsa05416	Viral myocarditis - Homo sapiens (human)	6/59	56/23216	2.45512737644e-05	0.000322191262522	CD28; CD40LG; CD86; ITGB2; ICAM1; CAV1	3689/940/942/959/3383/857	6	3	0.101694915254237	0.00241212956581668
path:hsa05167	Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)	10/186	186/23216	2.4783943271e-05	0.000322191262522	IRF3; IRF7; STAT2; STAT1; E2F1; IRF9; EIF2AK2; CD86; TLR3; ICAM1	3661/3665/6772/6773/10379/3383/1869/942/7098/5610	10	3	0.0537634408602151	0.00801171605789111
WP3617	Photodynamic therapy-induced NF-kB survival signaling	5/35	35/23216	2.91238449429e-05	0.000362498921097	RELB; BIRC5; CD40LG; NFKB2; ICAM1	332/959/4791/3383/5971	5	3	0.142857142857143	0.00150758097863542
WP1836	Interferon gamma signaling	3/7	7/23216	3.78484401418e-05	0.000451864030264	CIITA; PTAFR; SP100	4261/5724/6672	3	3	0.428571428571429	0.000301516195727085
path:hsa05321	Inflammatory bowel disease (IBD) - Homo sapiens (human)	6/65	63/23216	4.83987478009e-05	0.000555162107128	FOXP3; TGFB2; STAT4; STAT1; TBX21; TLR2	7042/7097/50943/30009/6772/6775	6	3	0.0923076923076923	0.00271364576154376
path:hsa04217	Necroptosis - Homo sapiens (human)	9/162	162/23216	4.95130857138e-05	0.000557022214281	STAT4; STAT2; NLRP3; IRF9; EIF2AK2; STAT1; TLR3; FASLG; PYCARD	6772/6773/6775/114548/10379/356/29108/7098/5610	9	3	0.0555555555555556	0.00697794624396968
path:hsa04064	NF-kappa B signaling pathway - Homo sapiens (human)	7/95	93/23216	5.20240020082e-05	0.000573646736986	DDX58; CD40LG; PRKCB; ICAM1; RELB; NFKB2; BTK	23586/4791/959/695/3383/5971/5579	7	3	0.0736842105263158	0.00400585802894555
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	8/127	127/23216	5.42529410882e-05	0.000577054009756	IRF3; RPS6KA1; ITGB2; IRF7; TLR2; TLR6; NFKB2; BTK	3665/6195/695/3661/7097/3689/10333/4791	8	3	0.062992125984252	0.00547036526533425
Pathway_TSLP	TSLP	4/21	21/23216	5.93677946292e-05	0.000595852479603	RELB; NFKB2; STAT4; STAT1	6772/4791/5971/6775	4	3	0.19047619047619	0.000904548587181254
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	3/8	8/23216	6.00945235839e-05	0.000595852479603	IRF3; TLR3; IRF7	7098/3661/3665	3	3	0.375	0.000344589937973811
path:hsa05140	Leishmaniasis - Homo sapiens (human)	6/74	70/23216	8.79859775646e-05	0.000857863281255	TGFB2; ITGB2; STAT1; PRKCB; NCF1; TLR2	7042/653361/5579/7097/3689/6772	6	3	0.0810810810810811	0.00301516195727085
path:hsa05152	Tuberculosis - Homo sapiens (human)	9/179	175/23216	9.00284303706e-05	0.000863387406013	CD74; CEBPB; TGFB2; ITGB2; STAT1; CIITA; PLK3; TLR2; TLR6	1051/10333/3689/6772/7042/4261/1263/7097/972	9	3	0.0502793296089385	0.00753790489317712
WP2865	IL1 and megakaryocytes in obesity	4/24	24/23216	0.000102873918332	0.000955257813082	TLR2; S100A9; ICAM1; NLRP3	114548/7097/3383/6280	4	3	0.166666666666667	0.00103376981392143
path:hsa05144	Malaria - Homo sapiens (human)	5/49	48/23216	0.000137799436729	0.00111708120419	TLR2; TGFB2; ITGB2; CD40LG; ICAM1	7042/7097/959/3383/3689	5	3	0.102040816326531	0.00206753962784287
WP4462	Platelet-mediated interactions with vascular and circulating cells	3/12	12/23216	0.000228956275093	0.00171717206319	TGFB2; CD40LG; ICAM1	959/3383/7042	3	3	0.25	0.000516884906960717
R-HSA-1169408	ISG15 antiviral mechanism	4/30	30/23216	0.000252749516326	0.00178142731386	IRF3; DDX58; EIF2AK2; STAT1	6772/5610/3661/23586	4	3	0.133333333333333	0.00129221226740179
WP2018	RANKL-RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	5/55	55/23216	0.000264076859752	0.00181747015241	RELB; NFKB2; SPI1; STAT1; ICAM1	6688/4791/3383/6772/5971	5	3	0.0909090909090909	0.00236905582356995
path:hsa05134	Legionellosis - Homo sapiens (human)	5/55	55/23216	0.000264076859752	0.00181747015241	TLR2; PYCARD; NFKB2; ITGB2; NLRC4	29108/4791/7097/3689/58484	5	3	0.0909090909090909	0.00236905582356995
path:hsa05323	Rheumatoid arthritis - Homo sapiens (human)	6/90	86/23216	0.000275331549567	0.00187289484299	TGFB2; ITGB2; CD86; TLR2; CD28; ICAM1	3689/3383/7042/940/942/7097	6	3	0.0666666666666667	0.00370434183321847
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	5/56	56/23216	0.000287559760339	0.00191992316708	IRF3; NLRC5; NFKB2; IRF7; DDX58	84166/4791/3661/3665/23586	5	3	0.0892857142857143	0.00241212956581668
R-HSA-918233	TRAF3-dependent IRF activation pathway	3/13	13/23216	0.000295372794936	0.00191992316708	IRF3; DDX58; IRF7	3661/3665/23586	3	3	0.230769230769231	0.000559958649207443
R-HSA-3270619	IRF3-mediated induction of type I IFN	3/13	13/23216	0.000295372794936	0.00191992316708	IRF3; IFI16; NLRC3	197358/3661/3428	3	3	0.230769230769231	0.000559958649207443
WP4329	miRNAs involvement in the immune response in sepsis	5/64	57/23216	0.000312593733914	0.00200953114659	RELB; IRF1; IRF7; NFKB2; ICAM1	3659/3383/3665/4791/5971	5	3	0.078125	0.0024552033080634
R-HSA-622312	Inflammasomes	3/15	15/23216	0.000462774761745	0.00263417627205	NLRC4; PYCARD; NLRP3	114548/58484/29108	3	3	0.2	0.000646106133700896
tollpathway	toll-like receptor pathway	4/35	35/23216	0.000463795138497	0.00263417627205	TLR2; TLR3; EIF2AK2; TLR6	7098/5610/7097/10333	4	3	0.114285714285714	0.00150758097863542
WP4136	Fibrin Complement Receptor 3 Signaling Pathway	4/36	36/23216	0.00051757710596	0.00288364387606	IRF3; TLR3; ITGB2; CXCL10	7098/3661/3627/3689	4	3	0.111111111111111	0.00155065472088215
path:hsa04933	AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human)	6/99	99/23216	0.000587600771049	0.00324289104777	TGFB2; STAT1; PRKCB; ICAM1; COL1A1; SERPINE1	6772/1277/3383/7042/5054/5579	6	3	0.0606060606060606	0.00426430048242591
WP4063	Interleukin-10 signaling	4/38	38/23216	0.000638209650717	0.00345696894139	CXCL10; PTAFR; ICAM1; CD86	3383/5724/3627/942	4	3	0.105263157894737	0.0016368022053756
path:hsa05142	Chagas disease (American trypanosomiasis) - Homo sapiens (human)	6/102	101/23216	0.000653405071804	0.00350680703675	TGFB2; TLR2; FASLG; TLR6; CD3D; SERPINE1	10333/7042/356/915/7097/5054	6	3	0.0588235294117647	0.00435044796691937
path:hsa04668	TNF signaling pathway - Homo sapiens (human)	6/110	110/23216	0.00102315609855	0.00498788598043	CEBPB; IRF1; RPS6KA4; ICAM1; CXCL10; BCL3	1051/3627/3659/602/8986/3383	6	3	0.0545454545454545	0.0047381116471399
WP2332	Interleukin-11 Signaling Pathway	4/44	44/23216	0.00111834235599	0.00521693469283	RPS6KA1; BIRC5; STAT1; ICAM1	332/3383/6772/6195	4	3	0.0909090909090909	0.00189524465885596
path:hsa05133	Pertussis - Homo sapiens (human)	5/76	76/23216	0.001177660565	0.00536295310504	IRF3; PYCARD; IRF1; ITGB2; NLRP3	29108/3659/3661/3689/114548	5	3	0.0657894736842105	0.00327360441075121
path:hsa05203	Viral carcinogenesis - Homo sapiens (human)	8/201	200/23216	0.00118259991547	0.00536295310504	IRF3; ACTN1; CCNA2; IRF9; EIF2AK2; IRF7; NFKB2; SP100	6672/3661/87/10379/4791/890/3665/5610	8	3	0.0398009950248756	0.00861474844934528
reg_gr_pathway	Glucocorticoid receptor regulatory network	5/80	80/23216	0.00148238591036	0.0065566022936	TBX21; IRF1; SPI1; ICAM1; STAT1	6772/6688/30009/3659/3383	5	3	0.0625	0.00344589937973811
R-HSA-1236975	Antigen processing-Cross presentation	4/49	48/23216	0.00155224410967	0.00677658809073	TLR2; NCF1; TLR6; BTK	653361/7097/10333/695	4	3	0.0816326530612245	0.00206753962784287
nfkappabalternativepathway	Alternative NF-kappaB pathway	2/6	6/23216	0.00158127826035	0.0068018219287	RELB; NFKB2	5971/4791	2	3	0.333333333333333	0.000258442453480358
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	3/23	23/23216	0.00169454978249	0.00718341755619	IRF3; NLRC5; DDX58	84166/23586/3661	3	3	0.130434782608696	0.000990696071674707
WP254	Apoptosis	5/87	84/23216	0.00184158174514	0.00758679803457	IRF3; FASLG; IRF1; IRF7; BIRC5	3659/3665/3661/332/356	5	3	0.0574712643678161	0.00361819434872502
R-HSA-1236974	ER-Phagosome pathway	3/24	24/23216	0.00192193204879	0.00785145004937	TLR2; TLR6; BTK	7097/10333/695	3	3	0.125	0.00103376981392143
WP1533	Vitamin B12 Metabolism	4/51	51/23216	0.00194608590967	0.00785145004937	NFKB2; APOE; SERPINE1; ICAM1	5054/3383/348/4791	4	3	0.0784313725490196	0.00219676085458305
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	3/27	27/23216	0.00271480187489	0.0100516398532	IRF3; TLR3; NFKB2	7098/3661/4791	3	3	0.111111111111111	0.00116299104066161
integrin2_pathway	Beta2 integrin cell surface interactions	3/30	29/23216	0.00334024711567	0.0114909018429	ITGB2; CD40LG; ICAM1	959/3689/3383	3	3	0.1	0.00124913852515507
pcafpathway	the information processing pathway at the ifn beta enhancer	3/29	29/23216	0.00334024711567	0.0114909018429	IRF3; IRF1; IRF7	3661/3665/3659	3	3	0.103448275862069	0.00124913852515507
R-HSA-844456	The NLRP3 inflammasome	2/10	10/23216	0.00461554883573	0.0140630003589	PYCARD; NLRP3	114548/29108	2	3	0.2	0.000430737422467264
path:hsa05145	Toxoplasmosis - Homo sapiens (human)	5/113	111/23216	0.00611681536333	0.0177609340933	TLR2; CIITA; TGFB2; CD40LG; STAT1	6772/959/4261/7042/7097	5	3	0.0442477876106195	0.00478118538938663
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	2/13	13/23216	0.00783793046917	0.0208078931122	IRF3; IRF7	3661/3665	2	3	0.153846153846154	0.000559958649207443
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	2/13	13/23216	0.00783793046917	0.0208078931122	NFKB2; IRF7	3665/4791	2	3	0.153846153846154	0.000559958649207443
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	2/15	15/23216	0.0104081212788	0.0256909322704	IRF3; TRIM21	3661/6737	2	3	0.133333333333333	0.000646106133700896
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	2/17	17/23216	0.0132986649403	0.0305087019219	TLR2; TLR6	7097/10333	2	3	0.117647058823529	0.000732253618194349
path:hsa05150	Staphylococcus aureus infection - Homo sapiens (human)	3/56	52/23216	0.0169802269145	0.0370650475558	ITGB2; PTAFR; ICAM1	5724/3383/3689	3	3	0.0535714285714286	0.00223983459682977
Pathway_RANKL	RANKL	2/23	23/23216	0.0237523922676	0.0464720718279	NFKB2; SPI1	6688/4791	2	3	0.0869565217391304	0.000990696071674707
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	2/23	23/23216	0.0237523922676	0.0464720718279	TLR3; NFKB2	7098/4791	2	3	0.0869565217391304	0.000990696071674707
R-HSA-933542	TRAF6 mediated NF-kB activation	2/26	26/23216	0.0298994141228	0.0555274833709	DDX58; NFKB2	23586/4791	2	3	0.0769230769230769	0.00111991729841489
R-HSA-216083	Integrin cell surface interactions	3/67	66/23216	0.0316619739874	0.0577335295848	ITGB2; LUM; ICAM1	4060/3689/3383	3	3	0.0447761194029851	0.00284286698828394
WP176	Folate Metabolism	3/66	66/23216	0.0316619739874	0.0577335295848	NFKB2; SERPINE1; ICAM1	5054/3383/4791	3	3	0.0454545454545455	0.00284286698828394
nthipathway	nfkb activation by nontypeable hemophilus influenzae	2/29	28/23216	0.0343093088419	0.0610059138983	TLR2; TGFB2	7042/7097	2	3	0.0689655172413793	0.00120606478290834
amb2_neutrophils_pathway	amb2 Integrin signaling	2/31	31/23216	0.0413621664155	0.0689369440259	ITGB2; ICAM1	3689/3383	2	3	0.0645161290322581	0.00133528600964852
WP619	Type II interferon signaling (IFNG)	10/37	37/23216	3.00594319726e-12	5.86158923466e-10	IRF1; SPI1; STAT2; STAT1; CIITA; IRF9; EIF2AK2; PSMB9; ICAM1; CXCL10	4261/3659/3383/6688/3627/10379/5610/6772/6773/5698	10	2	0.27027027027027	0.00159372846312888
il12_2pathway	IL12-mediated signaling events	8/65	61/23216	2.12069044107e-07	8.27069272017e-06	STAT4; STAT1; TBX21; CD4; FASLG; RELB; NFKB2; CD3D	5971/6772/6775/4791/920/30009/915/356	8	2	0.123076923076923	0.00262749827705031
WP4197	The human immune response to tuberculosis	5/22	22/23216	2.63439760168e-06	5.13707532328e-05	IRF1; PSMB8; IRF9; STAT1; STAT2	3659/10379/6772/6773/5696	5	2	0.227272727272727	0.000947622329427981
WP3945	TYROBP Causal Network	7/60	60/23216	2.821536029e-06	5.32451153859e-05	RPS6KA1; ITGB2; LYL1; CD4; HCLS1; PYCARD; PLEK	6195/3059/4066/3689/5341/29108/920	7	2	0.116666666666667	0.00258442453480358
nfat_tfpathway	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	6/49	49/23216	1.12253822425e-05	0.000172811805575	FOXP3; CD40LG; E2F1; TBX21; FASLG; IKZF1	959/1869/30009/50943/356/10320	6	2	0.122448979591837	0.00211061337008959
path:hsa05166	Human T-cell leukemia virus 1 infection - Homo sapiens (human)	11/219	217/23216	1.67033448443e-05	0.000244286418348	TGFB2; SPI1; CCNA2; E2F1; CD4; ITGB2; ICAM1; RELB; PTTG1; NFKB2; CD3D	9232/7042/6688/3689/4791/3383/1869/890/915/920/5971	11	2	0.0502283105022831	0.00934700206753963
rb_1pathway	Regulation of retinoblastoma protein	6/64	64/23216	5.29520064911e-05	0.000573646736986	CEBPB; CEBPA; SPI1; CCNA2; E2F1; TGFB2	1050/6688/1869/890/1051/7042	6	2	0.09375	0.00275671950379049
WP2374	Oncostatin M Signaling Pathway	6/65	65/23216	5.78416363649e-05	0.000593637846903	CEBPB; STAT1; PRKCH; PRKCB; OSM; SERPINE1	5054/1051/5583/5008/5579/6772	6	2	0.0923076923076923	0.00279979324603722
WP615	Senescence and Autophagy in Cancer	7/106	105/23216	0.000112689104084	0.00101359638423	CEBPB; IRF1; IRF7; E2F1; IFI16; COL1A1; SERPINE1	3659/3665/1869/5054/1051/1277/3428	7	2	0.0660377358490566	0.00452274293590627
path:hsa05200	Pathways in cancer - Homo sapiens (human)	16/526	525/23216	0.000114354463861	0.00101359638423	CEBPA; SPI1; PIM2; STAT2; STAT1; MECOM; E2F1; BIRC5; PRKCB; HMOX1; TGFB2; NOTCH3; STAT4; FASLG; NFKB2; LEF1	2122/356/332/6688/6772/6773/4791/4854/11040/1050/3162/7042/5579/6775/1869/51176	16	2	0.0304182509505703	0.0226137146795314
WP2849	Hematopoietic Stem Cell Differentiation	5/49	47/23216	0.000124480263874	0.00105537615023	FLI1; LYL1; LMO2; SPI1; IKZF1	10320/4066/4005/6688/2313	5	2	0.102040816326531	0.00202446588559614
WP2113	Type III interferon signaling	3/10	10/23216	0.000126813810229	0.00105980112834	IRF9; STAT2; STAT1	6772/6773/10379	3	2	0.3	0.000430737422467264
path:hsa05202	Transcriptional misregulation in cancer - Homo sapiens (human)	9/186	185/23216	0.000137574212018	0.00111708120419	CEBPB; CEBPA; SPI1; LYL1; ETV7; LMO2; FLI1; BCL11B; CD86	1050/1051/6688/2313/51513/64919/4005/942/4066	9	2	0.0483870967741935	0.00796864231564438
il27pathway	IL27-mediated signaling events	4/26	26/23216	0.000142412322813	0.00112582714656	TBX21; STAT4; STAT2; STAT1	6773/6772/6775/30009	4	2	0.153846153846154	0.00111991729841489
cmyb_pathway	C-MYB transcription factor network	6/85	84/23216	0.000242125973148	0.00177054617864	CEBPB; CEBPA; SPI1; TFEC; CD4; LEF1	22797/6688/920/1050/1051/51176	6	2	0.0705882352941176	0.00361819434872502
WP4149	White fat cell differentiation	4/32	32/23216	0.000326334878342	0.00207506417207	IRF3; CEBPB; CEBPA; MECOM	1050/1051/3661/2122	4	2	0.125	0.00137835975189524
WP2328	Allograft Rejection	6/91	89/23216	0.000331738831856	0.0020867442649	FOXP3; CD28; CD40LG; STAT1; CD86; FASLG	942/6772/959/50943/940/356	6	2	0.0659340659340659	0.00383356305995865
path:hsa04658	Th1 and Th2 cell differentiation - Homo sapiens (human)	6/92	90/23216	0.000352426890876	0.00219329501236	STAT4; STAT1; TBX21; NOTCH3; CD4; CD3D	6772/6775/4854/30009/920/915	6	2	0.0652173913043478	0.00387663680220538
WP236	Adipogenesis	7/131	130/23216	0.000421647402019	0.00256941385606	CEBPB; CEBPA; STAT1; STAT2; E2F1; OSM; SERPINE1	5008/6772/6773/1869/5054/1050/1051	7	2	0.0534351145038168	0.00559958649207443
path:hsa05146	Amoebiasis - Homo sapiens (human)	6/96	94/23216	0.000445484975686	0.00263417627205	ACTN1; ITGB2; PRKCB; TGFB2; TLR2; COL1A1	87/3689/1277/7042/7097/5579	6	2	0.0625	0.00404893177119228
il4_2pathway	IL4-mediated signaling events	5/65	62/23216	0.000463395754131	0.00263417627205	CEBPB; PARP14; SPI1; CD40LG; COL1A1	959/1277/54625/6688/1051	5	2	0.0769230769230769	0.00267057201929704
cd8tcrdownstreampathway	Downstream signaling in native CD8+ T cells	5/69	66/23216	0.000619032485701	0.00338442994519	TNFRSF4; FASLG; STAT4; CD3D; PRKCB	7293/6775/915/356/5579	5	2	0.072463768115942	0.00284286698828394
p53downstreampathway	Direct p53 effectors	7/143	141/23216	0.000686185939778	0.00361638535829	E2F1; PLK3; PRDM1; NLRC4; PYCARD; SERPINE1; CAV1	1869/639/29108/58484/5054/857/1263	7	2	0.048951048951049	0.00607339765678842
ifngpathway	IFN-gamma pathway	4/42	42/23216	0.000937064845091	0.00460657928049	CEBPB; IRF9; IRF1; STAT1	6772/10379/1051/3659	4	2	0.0952380952380952	0.00180909717436251
path:hsa04390	Hippo signaling pathway - Homo sapiens (human)	7/154	153/23216	0.00110969299398	0.00521693469283	TGFB2; ITGB2; BIRC5; STK3; TEAD2; LEF1; SERPINE1	3689/8463/6788/332/7042/5054/51176	7	2	0.0454545454545455	0.00659028256374914
R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription	3/20	20/23216	0.00111602731427	0.00521693469283	NOTCH3; STAT1; DLGAP5	6772/9787/4854	3	2	0.15	0.000861474844934528
path:hsa04670	Leukocyte transendothelial migration - Homo sapiens (human)	6/112	112/23216	0.0011236474723	0.00521693469283	NCF1; ITGB2; PRKCB; ACTN1; RHOH; ICAM1	653361/87/3689/3383/399/5579	6	2	0.0535714285714286	0.00482425913163336
path:hsa05205	Proteoglycans in cancer - Homo sapiens (human)	8/201	199/23216	0.00114517775353	0.00527503138435	DCN; TGFB2; PRKCB; TLR2; FASLG; HCLS1; LUM; CAV1	1634/5579/857/356/7042/7097/4060/3059	8	2	0.0398009950248756	0.00857167470709855
R-HSA-449147	Signaling by Interleukins	9/254	254/23216	0.00137778217349	0.00620001978072	RPS6KA1; STAT4; STAT1; IL16; CD4; LGALS9; OSM; NFKB2; HAVCR2	3965/920/84868/6772/6195/5008/3603/6775/4791	9	2	0.0354330708661417	0.0109407305306685
il2rbpathway	il-2 receptor beta chain in t cell activation	4/48	47/23216	0.00143437372026	0.00640540936146	FASLG; IKZF3; E2F1; NMI	356/1869/9111/22806	4	2	0.0833333333333333	0.00202446588559614
WP437	EGF-EGFR Signaling Pathway	7/162	161/23216	0.00149064633342	0.0065566022936	RPS6KA1; E2F1; STAT1; PLSCR1; PRKCB; MYBL2; CAV1	1869/4605/5579/6772/857/6195/5359	7	2	0.0432098765432099	0.00693487250172295
Pathway_IL11	IL11	3/23	23/23216	0.00169454978249	0.00718341755619	RPS6KA1; PRKCB; STAT1	6772/6195/5579	3	2	0.130434782608696	0.000990696071674707
WP3646	Hepatitis C and Hepatocellular Carcinoma	4/56	50/23216	0.00180791201926	0.00750091156927	BIRC5; FASLG; LEF1; RRM2	332/51176/6241/356	4	2	0.0714285714285714	0.00215368711233632
keratinocytepathway	keratinocyte differentiation	4/53	53/23216	0.00224404714527	0.00869382503298	PRKCH; CEBPA; PRKCB; FASLG	1050/5583/356/5579	4	2	0.0754716981132075	0.0022829083390765
WP395	IL-4 Signaling Pathway	4/54	54/23216	0.00240420453641	0.00923685784636	CEBPB; BIRC5; CEBPA; STAT1	332/1050/1051/6772	4	2	0.0740740740740741	0.00232598208132323
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	6/134	131/23216	0.00249957903115	0.00943389505305	ACTN1; TMSB4X; PRKCB; TGFB2; PLEK; SERPINE1	7042/5054/87/5341/5579/7114	6	2	0.0447761194029851	0.00564266023432116
WP560	TGF-beta Receptor Signaling	4/55	55/23216	0.00257205768752	0.00964521632821	LEF1; SERPINE1; STAT1; ENG	5054/51176/6772/2022	4	2	0.0727272727272727	0.00236905582356995
R-HSA-3000178	ECM proteoglycans	4/57	56/23216	0.00274778829731	0.0101097871316	DCN; TGFB2; LUM; SERPINE1	4060/1634/5054/7042	4	2	0.0701754385964912	0.00241212956581668
WP3972	PDGFR-beta pathway	3/29	29/23216	0.00334024711567	0.0114909018429	EIF2AK2; PRKCB; STAT1	5579/5610/6772	3	2	0.103448275862069	0.00124913852515507
R-HSA-5669034	TNFs bind their physiological receptors	3/29	29/23216	0.00334024711567	0.0114909018429	TNFRSF4; TNFSF8; FASLG	7293/944/356	3	2	0.103448275862069	0.00124913852515507
il2_stat5pathway	IL2 signaling events mediated by STAT5	3/30	30/23216	0.00368330240449	0.0119500773127	FASLG; FOXP3; CCNA2	50943/890/356	3	2	0.1	0.00129221226740179
aurora_a_pathway	Aurora A signaling	3/31	31/23216	0.00404709994246	0.0127975863045	BIRC5; AURKB; DLGAP5	9787/9212/332	3	2	0.0967741935483871	0.00133528600964852
Pathway_IL4	IL4	4/63	63/23216	0.00421339809793	0.0132518165983	CEBPB; CEBPA; SPI1; STAT1	1050/6772/6688/1051	4	2	0.0634920634920635	0.00271364576154376
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	3/33	32/23216	0.00443200667323	0.0137181158933	CEBPB; CEBPA; CAV1	1050/1051/857	3	2	0.0909090909090909	0.00137835975189524
ifnapathway	ifn alpha signaling pathway	2/10	10/23216	0.00461554883573	0.0140630003589	STAT2; STAT1	6772/6773	2	2	0.2	0.000430737422467264
path:hsa04659	Th17 cell differentiation - Homo sapiens (human)	5/107	105/23216	0.00484208191757	0.0146011233081	TBX21; FOXP3; CD3D; CD4; STAT1	6772/50943/30009/915/920	5	2	0.0467289719626168	0.00452274293590627
hif1_tfpathway	HIF-1-alpha transcription factor network	4/66	66/23216	0.00497715017842	0.0148552696652	ITGB2; HMOX1; SERPINE1; ENG	2022/5054/3162/3689	4	2	0.0606060606060606	0.00284286698828394
path:hsa05221	Acute myeloid leukemia - Homo sapiens (human)	4/66	66/23216	0.00497715017842	0.0148552696652	CEBPA; SPI1; PIM2; LEF1	6688/11040/1050/51176	4	2	0.0606060606060606	0.00284286698828394
path:hsa05143	African trypanosomiasis - Homo sapiens (human)	3/35	34/23216	0.00526652483291	0.0155601870063	PRKCB; FASLG; ICAM1	3383/5579/356	3	2	0.0857142857142857	0.0014645072363887
WP2853	Endoderm Differentiation	4/71	71/23216	0.00644732530305	0.0184461798245	TBX21; DAB2; LEF1; STAT1	51176/30009/1601/6772	4	2	0.0563380281690141	0.00305823569951757
il23pathway	IL23-mediated signaling events	3/37	37/23216	0.00668476944068	0.0184461798245	CD4; STAT4; STAT1	6772/6775/920	3	2	0.0810810810810811	0.00159372846312888
Pathway_Oncostatin_M	Oncostatin_M	3/38	38/23216	0.0072030459941	0.0197830136458	CEBPB; OSM; STAT1	6772/5008/1051	3	2	0.0789473684210526	0.0016368022053756
WP4211	Transcriptional cascade regulating adipogenesis	2/13	13/23216	0.00783793046917	0.0208078931122	CEBPB; CEBPA	1050/1051	2	2	0.153846153846154	0.000559958649207443
WP3944	Serotonin and anxiety-related events	2/13	13/23216	0.00783793046917	0.0208078931122	PRKCB; PLEK	5341/5579	2	2	0.153846153846154	0.000559958649207443
WP3892	Development of pulmonary dendritic cells and macrophage subsets	2/13	13/23216	0.00783793046917	0.0208078931122	SPI1; IKZF1	10320/6688	2	2	0.153846153846154	0.000559958649207443
WP127	IL-5 Signaling Pathway	3/40	40/23216	0.00830940373174	0.0217008981387	RPS6KA1; STAT1; BTK	695/6772/6195	3	2	0.075	0.00172294968986906
WP364	IL-6 signaling pathway	3/43	43/23216	0.0101467159923	0.0254756603241	IRF1; PRDM1; STAT1	3659/639/6772	3	2	0.0697674418604651	0.00185217091660924
R-HSA-114608	Platelet degranulation 	5/129	126/23216	0.0103035857218	0.0256909322704	TMSB4X; ACTN1; TGFB2; PLEK; SERPINE1	7114/7042/5054/87/5341	5	2	0.0387596899224806	0.00542729152308753
WP3	Phytochemical activity on NRF2 transcriptional activation	2/15	15/23216	0.0104081212788	0.0256909322704	CEBPB; HMOX1	1051/3162	2	2	0.133333333333333	0.000646106133700896
il6_7pathway	IL6-mediated signaling events	3/47	47/23216	0.0129359453121	0.0300298730459	CEBPB; IRF1; STAT1	6772/1051/3659	3	2	0.0638297872340425	0.00202446588559614
Pathway_IL5	IL5	3/48	48/23216	0.0136948587256	0.0312948920096	HCLS1; RPS6KA1; STAT1	6772/3059/6195	3	2	0.0625	0.00206753962784287
arenrf2pathway	oxidative stress induced gene expression via nrf2	2/18	18/23216	0.0148596067357	0.0333060150973	PRKCB; HMOX1	3162/5579	2	2	0.111111111111111	0.000775327360441075
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	3/50	50/23216	0.0152874227193	0.034004343311	CCNA2; FASLG; BCL3	356/890/602	3	2	0.06	0.00215368711233632
R-HSA-3000480	Scavenging by Class A Receptors	2/19	19/23216	0.0164953380204	0.0361414709436	APOE; COL1A1	348/1277	2	2	0.105263157894737	0.000818401102687801
WP4105	Transcriptional regulation by RUNX1	2/19	19/23216	0.0164953380204	0.0361414709436	SPI1; PRKCB	5579/6688	2	2	0.105263157894737	0.000818401102687801
R-HSA-447115	Interleukin-12 family signaling	2/19	19/23216	0.0164953380204	0.0361414709436	STAT4; STAT1	6772/6775	2	2	0.105263157894737	0.000818401102687801
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	3/53	53/23216	0.0178643977006	0.0382808522156	BIRC5; APOE; BCL3	602/332/348	3	2	0.0566037735849057	0.0022829083390765
egfpathway	egf signaling pathway	2/20	20/23216	0.0182041503211	0.0385272037895	PRKCB; STAT1	6772/5579	2	2	0.1	0.000861474844934528
WP23	B Cell Receptor Signaling Pathway	4/98	97/23216	0.0187013275584	0.0393535130275	HCLS1; RPS6KA1; PRKCB; BTK	695/5579/6195/3059	4	2	0.0408163265306122	0.00417815299793246
txa2pathway	Thromboxane A2 receptor signaling	3/57	56/23216	0.0206685803644	0.0427248039334	PRKCH; PRKCB; ICAM1	5583/5579/3383	3	2	0.0526315789473684	0.00241212956581668
mapkpathway	mapkinase signaling pathway	3/57	57/23216	0.0216539694642	0.0435941181559	RPS6KA1; CEBPA; STAT1	1050/6772/6195	3	2	0.0526315789473684	0.0024552033080634
R-HSA-6783589	Interleukin-6 family signaling	2/22	22/23216	0.021834319008	0.0435941181559	OSM; STAT1	6772/5008	2	2	0.0909090909090909	0.000947622329427981
ghpathway	growth hormone signaling pathway	2/23	23/23216	0.0237523922676	0.0464720718279	RPS6KA1; PRKCB	6195/5579	2	2	0.0869565217391304	0.000990696071674707
fcer1pathway	Fc-epsilon receptor I signaling in mast cells	3/62	61/23216	0.0258490838439	0.0504057134956	HCLS1; PRKCB; BTK	3059/5579/695	3	2	0.0483870967741935	0.00262749827705031
lymphangiogenesis_pathway	VEGFR3 signaling in lymphatic endothelium	2/25	25/23216	0.0277865040435	0.0529482243173	RPS6KA1; COL1A1	1277/6195	2	2	0.08	0.00107684355616816
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	2/25	25/23216	0.0277865040435	0.0529482243173	SERPINE1; ENG	5054/2022	2	2	0.08	0.00107684355616816
alk1pathway	ALK1 signaling events	2/26	26/23216	0.0298994141228	0.0555274833709	CAV1; ENG	2022/857	2	2	0.0769230769230769	0.00111991729841489
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	3/66	66/23216	0.0316619739874	0.0577335295848	RPS6KA1; STAT1; E2F1	1869/6772/6195	3	2	0.0454545454545455	0.00284286698828394
il3_pathway	IL3-mediated signaling events	2/28	27/23216	0.0320741831027	0.0577335295848	CEBPB; OSM	5008/1051	2	2	0.0714285714285714	0.00116299104066161
WP3845	Canonical and Non-canonical Notch signaling	2/27	27/23216	0.0320741831027	0.0577335295848	LEF1; NOTCH3	51176/4854	2	2	0.0740740740740741	0.00116299104066161
R-HSA-437239	Recycling pathway of L1	2/29	28/23216	0.0343093088419	0.0610059138983	RPS6KA1; RPS6KA4	8986/6195	2	2	0.0689655172413793	0.00120606478290834
WP3802	TP53 Regulates Transcription of Cell Death Genes	2/29	29/23216	0.0366033134143	0.0635133347023	NLRC4; BIRC5	332/58484	2	2	0.0689655172413793	0.00124913852515507
vegfr1_pathway	VEGFR1 specific signals	2/29	29/23216	0.0366033134143	0.0635133347023	PRKCB; CAV1	857/5579	2	2	0.0689655172413793	0.00124913852515507
tcrcalciumpathway	Calcium signaling in the CD4+ TCR pathway	2/29	29/23216	0.0366033134143	0.0635133347023	FASLG; CD40LG	959/356	2	2	0.0689655172413793	0.00124913852515507
WP2001	miR-targeted genes in adipocytes - TarBase	2/34	29/23216	0.0366033134143	0.0635133347023	CEBPB; CYP1B1	1051/1545	2	2	0.0588235294117647	0.00124913852515507
fcer1pathway	fc epsilon receptor i signaling in mast cells	2/29	29/23216	0.0366033134143	0.0635133347023	PRKCB; BTK	5579/695	2	2	0.0689655172413793	0.00124913852515507
myc_represspathway	Validated targets of C-MYC transcriptional repression	3/74	71/23216	0.0381011497583	0.0651730193234	CEBPA; SPI1; SLC11A1	1050/6688/6556	3	2	0.0405405405405405	0.00305823569951757
WP4216	Chromosomal and microsatellite instability in colorectal cancer	3/73	73/23216	0.0408499245324	0.0684733692019	BIRC5; LEF1; TGFB2	332/51176/7042	3	2	0.0410958904109589	0.00314438318401103
path:hsa05100	Bacterial invasion of epithelial cells - Homo sapiens (human)	3/74	74/23216	0.0422609965089	0.0700359290586	HCLS1; RHOG; CAV1	391/857/3059	3	2	0.0405405405405405	0.00318745692625775
Pathway_IL6	IL6	3/74	74/23216	0.0422609965089	0.0700359290586	CEBPB; BTK; STAT1	6772/1051/695	3	2	0.0405405405405405	0.00318745692625775
path:hsa05212	Pancreatic cancer - Homo sapiens (human)	3/75	75/23216	0.0436963700918	0.0716121329135	TGFB2; STAT1; E2F1	7042/1869/6772	3	2	0.04	0.00323053066850448
WP3893	Development and heterogeneity of the ILC family	2/32	32/23216	0.043824177065	0.0716121329135	TBX21; BCL11B	64919/30009	2	2	0.0625	0.00137835975189524
smad2_3nuclearpathway	Regulation of nuclear SMAD2/3 signaling	3/78	76/23216	0.0451559220149	0.0731751090824	CEBPB; IRF7; SERPINE1	5054/3665/1051	3	2	0.0384615384615385	0.00327360441075121
path:hsa05220	Chronic myeloid leukemia - Homo sapiens (human)	3/76	76/23216	0.0451559220149	0.0731751090824	MECOM; TGFB2; E2F1	7042/2122/1869	3	2	0.0394736842105263	0.00327360441075121
path:hsa04068	FoxO signaling pathway - Homo sapiens (human)	4/132	129/23216	0.0462063404197	0.073464887122	PLK1; TGFB2; FASLG; PLK3	5347/356/7042/1263	4	2	0.0303030303030303	0.0055565127498277
integrinpathway	integrin signaling pathway	2/33	33/23216	0.0463393903385	0.073464887122	ACTN1; CAV1	857/87	2	2	0.0606060606060606	0.00142143349414197
epopathway	EPO signaling pathway	2/33	33/23216	0.0463393903385	0.073464887122	BTK; STAT1	6772/695	2	2	0.0606060606060606	0.00142143349414197
WP3995	Prion disease pathway	2/33	33/23216	0.0463393903385	0.073464887122	BATF; SPI1	10538/6688	2	2	0.0606060606060606	0.00142143349414197
WP400	p38 MAPK Signaling Pathway	2/34	34/23216	0.0489064444326	0.0771166307091	TGFB2; STAT1	7042/6772	2	2	0.0588235294117647	0.0014645072363887
WP1858	Mitotic G1-G1-S phases	7/20	20/23216	8.01315519716e-10	5.85961973793e-08	CCNA2; E2F1; ORC1; RRM2; CDC45; MYBL2; CDC6	890/990/1869/6241/4605/8318/4998	7	1	0.35	0.000861474844934528
e2f_pathway	E2F transcription factor network	9/75	73/23216	6.21647880349e-08	3.0305334167e-06	E2F7; CEBPA; CCNA2; E2F1; ORC1; RRM2; MYBL2; SERPINE1; CDC6	1050/4605/5054/6241/4998/1869/990/890/144455	9	1	0.12	0.00314438318401103
R-HSA-539107	Activation of E2F1 target genes at G1/S	5/17	17/23216	6.45564949459e-07	1.64198041493e-05	CDC45; CDC6; RRM2; E2F1; ORC1	6241/4998/1869/8318/990	5	1	0.294117647058824	0.000732253618194349
foxm1pathway	FOXM1 transcription factor network	6/42	42/23216	4.47066074601e-06	8.1729266763e-05	CCNA2; PLK1; CENPF; BIRC5; FOXM1; AURKB	5347/9212/1063/890/332/2305	6	1	0.142857142857143	0.00180909717436251
R-HSA-156711	Polo-like kinase mediated events	4/16	16/23216	1.88002606265e-05	0.000255770987594	PLK1; CENPF; MYBL2; FOXM1	2305/1063/5347/4605	4	1	0.25	0.000689179875947622
WP179	Cell Cycle	8/120	120/23216	3.61504001523e-05	0.000440583001856	TGFB2; CCNA2; E2F1; PLK1; ORC1; CDC45; PTTG1; CDC6	990/5347/7042/1869/9232/890/8318/4998	8	1	0.0666666666666667	0.00516884906960717
R-HSA-1538133	G0 and Early G1	4/25	25/23216	0.000121481721473	0.00105537615023	MYBL2; CCNA2; CDC6; E2F1	4605/1869/990/890	4	1	0.16	0.00107684355616816
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	3/11	11/23216	0.000173037712064	0.0013496941541	MYBL2; CCNA2; E2F1	890/1869/4605	3	1	0.272727272727273	0.00047381116471399
WP3804	TP53 Regulates Transcription of Cell Cycle Genes	3/13	13/23216	0.000295372794936	0.00191992316708	E2F7; PLK3; E2F1	144455/1263/1869	3	1	0.230769230769231	0.000559958649207443
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	3/14	14/23216	0.000373062825276	0.00229728160828	E2F7; CCNA2; E2F1	890/1869/144455	3	1	0.214285714285714	0.00060303239145417
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	4/41	40/23216	0.000777530608656	0.00398995970231	PLK1; PTTG1; CCNA2; AURKB	5347/9232/9212/890	4	1	0.0975609756097561	0.00172294968986906
WP1859	Mitotic G2-G2-M phases	2/5	5/23216	0.00106145030042	0.00508974119465	PLK1; CENPF	1063/5347	2	1	0.4	0.000215368711233632
R-HSA-68911	G2 Phase	2/5	5/23216	0.00106145030042	0.00508974119465	CCNA2; E2F1	1869/890	2	1	0.4	0.000215368711233632
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	3/25	25/23216	0.00216744800252	0.00845304720983	PLK1; FOXM1; CCNA2	5347/890/2305	3	1	0.12	0.00107684355616816
R-HSA-68949	Orc1 removal from chromatin	3/26	26/23216	0.00243158309118	0.00923685784636	CCNA2; CDC6; ORC1	4998/990/890	3	1	0.115384615384615	0.00111991729841489
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	3/27	26/23216	0.00243158309118	0.00923685784636	PLK1; PTTG1; AURKB	5347/9232/9212	3	1	0.111111111111111	0.00111991729841489
WP2361	Gastric Cancer Network 1	3/29	27/23216	0.00271480187489	0.0100516398532	E2F7; CENPF; MYBL2	144455/4605/1063	3	1	0.103448275862069	0.00116299104066161
R-HSA-68689	CDC6 association with the ORC:origin complex	2/8	8/23216	0.00291150207671	0.0105137574992	CDC6; ORC1	4998/990	2	1	0.25	0.000344589937973811
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	3/32	31/23216	0.00404709994246	0.0127975863045	PLK1; PTTG1; CCNA2	5347/9232/890	3	1	0.09375	0.00133528600964852
WP4413	Transcriptional Regulation by E2F6	2/10	10/23216	0.00461554883573	0.0140630003589	RRM2; E2F1	1869/6241	2	1	0.2	0.000430737422467264
fra_pathway	Validated transcriptional targets of AP1 family members Fra1 and Fra2	3/37	37/23216	0.00668476944068	0.0184461798245	DCN; CCNA2; HMOX1	1634/3162/890	3	1	0.0810810810810811	0.00159372846312888
atr_pathway	ATR signaling pathway	3/37	37/23216	0.00668476944068	0.0184461798245	PLK1; CCNA2; CDC6	5347/990/890	3	1	0.0810810810810811	0.00159372846312888
WP4086	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	2/14	14/23216	0.00908207507649	0.0233026926305	APOE; MYBL2	348/4605	2	1	0.142857142857143	0.00060303239145417
p73pathway	p73 transcription factor network	4/79	79/23216	0.00935428278511	0.02379241491	PLK1; PLK3; CCNA2; SERPINE1	5347/1263/5054/890	4	1	0.0506329113924051	0.00340282563749139
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	2/16	16/23216	0.0118142485449	0.0279811149747	E2F1; CDC6	990/1869	2	1	0.125	0.000689179875947622
R-HSA-113510	E2F mediated regulation of DNA replication	2/22	22/23216	0.021834319008	0.0435941181559	E2F1; ORC1	4998/1869	2	1	0.0909090909090909	0.000947622329427981
WP4320	The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome	2/22	22/23216	0.021834319008	0.0435941181559	LEF1; E2F1	51176/1869	2	1	0.0909090909090909	0.000947622329427981
WP4286	Genotoxicity pathway	3/64	64/23216	0.0292612118068	0.055041186196	E2F7; PLK3; TRIM22	1263/144455/10346	3	1	0.046875	0.00275671950379049
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	2/28	27/23216	0.0320741831027	0.0577335295848	CCNA2; CDC6	990/890	2	1	0.0714285714285714	0.00116299104066161
R-HSA-1912408	Pre-NOTCH Transcription and Translation	2/30	30/23216	0.0389547427721	0.0658627876349	E2F1; NOTCH3	1869/4854	2	1	0.0666666666666667	0.00129221226740179
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	2/31	30/23216	0.0389547427721	0.0658627876349	PTTG1; CCNA2	9232/890	2	1	0.0645161290322581	0.00129221226740179
il12_stat4pathway	IL12 signaling mediated by STAT4	7/32	30/23216	1.92930574261e-08	1.12864385943e-06	IRF1; CD28; TBX21; CD86; CD4; STAT4; CD3D	942/6775/940/920/30009/915/3659	7	5	0.21875	0.00129221226740179
path:hsa05340	Primary immunodeficiency - Homo sapiens (human)	5/37	35/23216	2.91238449429e-05	0.000362498921097	CD4; CD40LG; CD3D; BTK; CIITA	915/920/695/959/4261	5	5	0.135135135135135	0.00150758097863542
tcr_pathway	TCR signaling in native CD4+ T cells	6/68	65/23216	5.78416363649e-05	0.000593637846903	CD28; PRKCB; SLA2; CD86; CD4; CD3D	942/84174/940/920/915/5579	6	5	0.0882352941176471	0.00279979324603722
WP453	Inflammatory Response Pathway	4/33	30/23216	0.000252749516326	0.00178142731386	CD28; CD86; CD40LG; COL1A1	959/1277/942/940	4	5	0.121212121212121	0.00129221226740179
path:hsa05330	Allograft rejection - Homo sapiens (human)	4/38	35/23216	0.000463795138497	0.00263417627205	CD40LG; CD28; FASLG; CD86	940/942/356/959	4	5	0.105263157894737	0.00150758097863542
path:hsa04612	Antigen processing and presentation - Homo sapiens (human)	5/77	69/23216	0.000759277227866	0.00396586766341	CD4; CD74; PSME2; CIITA; PSME1	920/972/5720/5721/4261	5	5	0.0649350649350649	0.00297208821502412
ctla4pathway	the co-stimulatory signal during t-cell activation	3/20	18/23216	0.000811130577278	0.00409139372873	CD28; CD3D; CD86	942/940/915	3	5	0.15	0.000775327360441075
mef2dpathway	role of mef2d in t-cell apoptosis	3/30	28/23216	0.00301754849187	0.0108298519494	CD4; PRKCB; CD3D	920/915/5579	3	5	0.1	0.00120606478290834
WP4146	Macrophage markers	2/9	9/23216	0.00371780183063	0.0119500773127	CD74; CD86	972/942	2	5	0.222222222222222	0.000387663680220538
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	4/63	61/23216	0.00375085298931	0.0119904316871	CD4; CD3D; CD28; CD40LG	959/940/915/920	4	5	0.0634920634920635	0.00262749827705031
tcrapathway	lck and fyn tyrosine kinases in initiation of tcr activation	2/13	11/23216	0.00560277352987	0.0163881125749	CD4; CD3D	920/915	2	5	0.153846153846154	0.00047381116471399
R-HSA-389359	CD28 dependent Vav1 pathway	2/12	12/23216	0.00667753698083	0.0184461798245	CD28; CD86	942/940	2	5	0.166666666666667	0.000516884906960717
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	2/22	21/23216	0.019984362225	0.041456921637	CD4; CD28	940/920	2	5	0.0909090909090909	0.000904548587181254
R-HSA-449836	Other interleukin signaling	2/26	26/23216	0.0298994141228	0.0555274833709	CD4; IL16	920/3603	2	5	0.0769230769230769	0.00111991729841489
path:hsa03050	Proteasome - Homo sapiens (human)	5/45	45/23216	0.000100816535133	0.000951252791174	PSMB10; PSME2; PSME1; PSMB9; PSMB8	5696/5698/5699/5720/5721	5	4	0.111111111111111	0.00193831840110269
mhcpathway	antigen processing and presentation	3/12	12/23216	0.000228956275093	0.00171717206319	CD74; PSMB9; PSMB8	5696/972/5698	3	4	0.25	0.000516884906960717
R-HSA-6799990	Metal sequestration by antimicrobial proteins	2/6	6/23216	0.00158127826035	0.0068018219287	S100A9; S100A8	6279/6280	2	6	0.333333333333333	0.000258442453480358
WP3644	NAD+ metabolism	2/16	16/23216	0.0118142485449	0.0279811149747	CD38; SIRT7	51547/952	2	7	0.125	0.000689179875947622
WP3967	miR-509-3p alteration of YAP1-ECM axis	2/18	18/23216	0.0148596067357	0.0333060150973	TEAD2; COL1A1	1277/8463	2	8	0.111111111111111	0.000775327360441075
WP3640	Imatinib and Chronic Myeloid Leukemia	2/21	21/23216	0.019984362225	0.041456921637	PIM2; LYL1	4066/11040	2	9	0.0952380952380952	0.000904548587181254
path:hsa04392	Hippo signaling pathway - multiple species - Homo sapiens (human)	2/29	28/23216	0.0343093088419	0.0610059138983	TEAD2; STK3	6788/8463	2	10	0.0689655172413793	0.00120606478290834
R-HSA-1222556	ROS, RNS production in phagocytes	2/32	32/23216	0.043824177065	0.0716121329135	NCF1; SLC11A1	653361/6556	2	11	0.0625	0.00137835975189524
